Share on LinkedInShare on LinkedIn

ARTICLE · 05 NOVEMBER 2020

Importance Of Issuer Specific Disclosure During COVID-19 Highlighted By CSA Continuous Disclosure Review Program

The Staff Notice highlights deficiencies related to financial statement disclosure, management's discussion and analysis (MD&A) and other general regulatory requirements.

CanadaCoronavirus (COVID-19)

The Canadian Securities Administrators (CSA) have published a Staff Notice reporting on the results of their continuous disclosure review program (Review Program) which, in light of current circumstances, has a particular focus on guidance for issuers in addressing the impact of COVID-19, including examples of both deficient and improved disclosure specifically related to COVID-19.

  • The Staff Notice highlights deficiencies related to financial statement disclosure, management's discussion and analysis (MD&A) and other general regulatory requirements.
  • Issuers are specifically reminded that disclosure should be transparent and entity-specific, especially in light of the current economic climate and the COVID-19 pandemic.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from